nVerses Capital’s Aspen Aerogels ASPN Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPN
KL
OCMI
VCM
NIM
GKFF
RHJA
nVerses Capital's ASPN Position: Q2 2026 in Review
nVerses Capital reduced its Aspen Aerogels (ASPN) stake by 38% in Q2 2026, selling an estimated $75.1K and leaving 25,234 shares worth $160K. The position accounts for 0.25% of the portfolio, ranked #210.
nVerses Capital first reported a position in ASPN in Q2 2024 and has held it in 4 quarters since. The position peaked at $161K in Q3 2024. 130 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.
- nVerses Capital held 25,234 shares of Aspen Aerogels worth $160K as of Q2 2026.
- nVerses Capital sold 15,312 Aspen Aerogels shares in Q2 2026, an estimated $75.1K.
- Aspen Aerogels made up 0.25% of nVerses Capital's portfolio in Q2 2026, its #210 holding.
- nVerses Capital first reported a position in Aspen Aerogels in Q2 2024 and has held it in 4 quarters since.
- nVerses Capital's Aspen Aerogels position peaked at $161K in Q3 2024.
- 130 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.
Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.